Anya Biopharm (ROCO:7776) EPS (Diluted): NT$-1.30 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7776 Anya Biopharm Inc ROCO:7776
12 GF Score
Price NT$31.00
! 4 Warning Signs
View Full Analysis

What is Anya Biopharm EPS (Diluted)?

Anya Biopharm ROCO:7776 -4.91% 12 EPS (Diluted) is NT$-1.30 as of Dec. 2025. GuruFocus rates ROCO:7776 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Anya Biopharm's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was NT$0.09. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.30.

Anya Biopharm's EPS (Basic) for the six months ended in Dec. 2025 was NT$0.09. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.30.

Anya Biopharm's EPS without NRI for the six months ended in Dec. 2025 was NT$0.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.30.

During the past 3 years, the average EPS without NRIGrowth Rate was 58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Anya Biopharm's highest 3-Year average EPS without NRI Growth Rate was 58.60% per year. The lowest was 58.60% per year. And the median was 58.60% per year.

Anya Biopharm  (ROCO:7776) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Anya Biopharm EPS (Diluted) Related Terms

Anya Biopharm EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Anya Biopharm's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anya Biopharm EPS (Diluted) Chart

Anya Biopharm Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
-18.35 -12.32 -1.12 -1.30

Anya Biopharm Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Diluted) Get a 7-Day Free Trial -0.88 -1.79 -0.14 -1.39 0.09

ROCO:7776 vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, Anya Biopharm's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anya Biopharm PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anya Biopharm's PE Ratio distribution charts can be found below:

* The bar in red indicates where Anya Biopharm's PE Ratio falls into.


ROCO:7776
12GF Score
Anya Biopharm Inc ROCO:7776
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anya Biopharm EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Anya Biopharm's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-64.022-0)/49.101
=-1.30

Anya Biopharm's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(4.283-0)/49.101
=0.09

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of NT$-1.30 mean?
Anya Biopharm (ROCO:7776) has a EPS (Diluted) of NT$-1.30 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Anya Biopharm and its competitors.
Is Anya Biopharm's EPS (Diluted) too high?
Anya Biopharm's current EPS (Diluted) is NT$-1.30. Overall, Anya Biopharm has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Anya Biopharm's EPS (Diluted) compare to VRTX and REGN?
Anya Biopharm's EPS (Diluted) of NT$-1.30 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Anya Biopharm and its competitors. Anya Biopharm's current EPS (Diluted) is NT$-1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anya Biopharm stock overvalued right now?
Anya Biopharm (ROCO:7776) has a current EPS (Diluted) of NT$-1.30. The current EPS (Diluted) is NT$-1.30. Anya Biopharm's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Anya Biopharm (ROCO:7776), the current EPS (Diluted) is NT$-1.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anya Biopharm Business Description

Address No. 3-2, Yuanqu Street, 4th Floor, Nangang, Taipei, TWN, 115603
Anya Biopharm Inc is a pharmaceutical company engaged in the Oral Delivery of Peptides. Its patented technology platform Mira/Je is a flexible solution easy to adapt to a large variety of peptides.
12GF Score

Get the complete analysis for ROCO:7776

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.00
Price